Parkinson's Disease Related Depression and Anxiety: A 22-Year Bibliometric Analysis (2000-2022)
Tong Zhang,Rui Yang,Juhua Pan,Shijing Huang
DOI: https://doi.org/10.2147/NDT.S403002
IF: 2.989
2023-06-30
Neuropsychiatric Disease and Treatment
Abstract:Tong Zhang, &ast Rui Yang, &ast Juhua Pan, Shijing Huang Research and Development Center of Traditional Chinese Medicine, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Shijing Huang; Juhua Pan, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, People's Republic of China, Email ; Background: Parkinson's disease (PD) is one of the common neurodegenerative diseases. Depression and anxiety are the most common psychiatric symptoms of PD. It is important to study the potential relationship between PD and depression or anxiety. Aim: This study aimed to use bibliometrics to analyze the papers about parkinson's disease related depression and anxiety over the last 22 years, and to characterize the current status of research and predict future hotspots. Methods: In the Web of Science Core Collection (WoSCC) from 2000 to 2022, documents are searched according to specific subject words. The selected literature was retrospectively analyzed and mapped using CiteSpace and Vosviewer software. We analyzed countries, institutions, journals, authors, references and keywords. Results: A total of 7368 papers were included from 2000 to 2022, and the number of publications has shown an upward trend year by year. Movement Disorder is the journal with the highest number of publications (391 publications, 5.31%) and citations (30,549 times), with the United States (2055 publications, 27.9%) and the University of Toronto (158 publications) being the countries and institutions with the highest number of publications. The high-frequency keywords focused on "quality of life", "deep brain stimulation" and "non-motor symptoms". "Functional connectivity", "gut microbiota" and "inflammation" may be at the forefront of future research. Conclusion: Parkinson's disease related depression and anxiety have been increasingly studied over the past 22 years. Functional connectivity, gut microbiota, and inflammation will be the subject of active research hotspots in the future, and these findings may provide new research ideas for researchers. Keywords: Parkinson's disease, depression, anxiety, bibliometric analysis, Citespace, VOSviewer Parkinson's disease (PD) is a common degenerative disease of the central nervous system that involves the progressive impairment of voluntary motor control. 1 The main symptoms of PD include motor retardation, static tremors and rigidity, as well as changes in posture and gait. Some PD patients also have clinical symptoms of dysphagia and dysarthria. 2,3 These motor symptoms tend to develop gradually and worsen with age, severely reducing the quality of life for the sufferer. According to the Global Burden of Disease Study, the number of cases of PD increased 118% between 1990 and 2015, making it the fastest-growing neurological disorder in the world. 4 There is no doubt that motor symptoms are the main clinical manifestations of PD, but non-motor symptoms such as anxiety, depression, constipation, urinary dysfunction, memory loss, pain and sleep disorders are also worthy of our attention, some of which can be almost throughout the course of PD. 5,6 Anxiety and depression are the most common and prominent affective disorders of PD, 7 with 30–35% of patients having obvious above symptoms, 8 and both of them often appear simultaneously in the course of the patient's disease. Depressive symptoms are considered to be the earliest non-motor symptoms of PD, and their incidence increases with age. 9 In the advanced stages of PD, about 60% of patients will have some degree of depressive symptoms. 6 Anxiety includes generalized anxiety, panic disorder, and social phobia. 10 There are many causes of anxiety and depression in people with PD, including care dependency, decline in daily activities, rapid decline in physical and cognitive abilities, and fear of exacerbation and death. 7,11–13 These affective disorders not only directly affect the quality of life of patients with PD, 14 but also accelerate the progress of the disease, which is related to the deterioration of motor symptoms. 15 These disorders are often more problematic and distressing for patients and families than the motor aspects of PD. 16 But so far, little is known about depression and anxiety disorders in PD, and management and treatment approaches are limited. 17,18 Current research links defects in dopaminergic and non-dopaminergic function, abnormalities in brain structure and metabolism, and inflammation during the cour -Abstract Truncated-
psychiatry,clinical neurology